The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting
Open accessAbstract
Hepatocelluar carcinoma (HCC) is the most common primary malignancy of the liver in adults and the third most common cause of cancer death worldwide. The incidence of HCC in the United States is rising steadily because of the prevalence of hepatitis C viral infection and other causes of hepatic cirrhosis. The majority of patients have underlying hepatic dysfunction, which complicates patient management and the search for safe and effective therapies. The Clinical Trials Planning Meeting (CTPM) in HCC was convened by the National Cancer Institute's Gastrointestinal Cancer Steering Committee to identify the key knowledge gaps in HCC and define clinical research priorities. The CTPM structured its review according to current evidence-based treatment modalities in HCC and prioritized the recommendations on the basis of the patient populations representing the greatest unmet medical need.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534
Self-citationSorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Edge, S. B., & Compton, C. C. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-0985-4 · Cited by 9,029
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186
Management of Hepatocellular Carcinoma *
Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,857
Cheng, A.-L., Kang, Y.-K., Chen, Z., Tsao, C.-J., Qin, S., Kim, J. S., Luo, R., Feng, J., Ye, S., Yang, T.-S., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70285-7 · Cited by 5,832
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification
Llovet, J., Brú, C., & Bruix, J. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007122 · Cited by 3,805
Llovet, J. M., Real, M. I., Montaña, X., Planas, R., Coll, S., Aponte, J., Ayuso, C., Sala, M., Muchart, J., Solà, R., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08649-x · Cited by 3,494
Rising Incidence of Hepatocellular Carcinoma in the United States
El-Serag, H. B., & Mason, A. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401001 · Cited by 2,853
Lo, C.-M., Ngan, H., Tso, W.-K., Liu, C.-L., Lam, C.-M., Poon, R. T.-P., Fan, S.-T., & Wong, J. (2002) · Hepatology · doi:10.1053/jhep.2002.33156 · Cited by 2,613
Self-citationPerz, J. F., Armstrong, G. L., Farrington, L. A., Hutin, Y. J. F., & Bell, B. P. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.05.013 · Cited by 2,572
Primary liver cancer: Worldwide incidence and trends
Bosch, F. X., Ribes, J., Díaz, M., & Cléries, R. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.011 · Cited by 2,477
Yao, F. Y., Ferrell, L., Bass, N. M., Watson, J. J., Bacchetti, P., Venook, A., Ascher, N. L., & Roberts, J. P. (2001) · Hepatology · doi:10.1053/jhep.2001.24563 · Cited by 2,262
Self-citationEdwards, B. K., Ward, E., Kohler, B. A., Eheman, C., Zauber, A. G., Anderson, R. N., Jemal, A., Schymura, M. J., Lansdorp‐Vogelaar, I., Seeff, L. C., et al. (2010) · Cancer · doi:10.1002/cncr.24760 · Cited by 2,002
Okuda, K., Ohtsuki, T., Obata, H., Tomimatsu, M., Okazaki, N., Hasegawa, H., Nakajima, Y., & Ohnishi, K. (1985) · Cancer · doi:10.1002/1097-0142(19850815)56:4<918::aid-cncr2820560437>3.0.co;2-e · Cited by 1,931
Llovet, J. M., Fuster, J., & Bruix, J. (1999) · Hepatology · doi:10.1002/hep.510300629 · Cited by 1,708
Small Hepatocellular Carcinoma: Treatment with Radio-frequency Ablation versus Ethanol Injection
Livraghi, T., Goldberg, S. N., Lazzaroni, S., Meloni, F., Solbiati, L., & Gazelle, G. S. (1999) · Radiology · doi:10.1148/radiology.210.3.r99fe40655 · Cited by 1,283
Phase II Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma
Abou-Alfa, G. K., Schwartz, L., Ricci, S., Amadori, D., Santoro, A., Figer, A., De Greve, J., Douillard, J.-Y., Lathia, C., Schwartz, B., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.3441 · Cited by 1,195
Self-citationTrends in the Leading Causes of Death in the United States, 1970-2002
Jemal, A. (2005) · JAMA · doi:10.1001/jama.294.10.1255 · Cited by 987
Budhu, A., Forgues, M., Ye, Q.-H., Jia, H.-L., He, P., Zanetti, K. A., Kammula, U. S., Chen, Y., Qin, L.-X., Tang, Z.-Y., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.06.016 · Cited by 846
Poon, R. T.-P., Fan, S. T., Lo, C. M., Liu, C. L., & Wong, J. (2002) · Annals of Surgery · doi:10.1097/00000658-200203000-00009 · Cited by 844
Self-citation(1995) · New England Journal of Medicine · doi:10.1056/nejm199505113321903 · Cited by 809
Marelli, L., Stigliano, R., Triantos, C., Senzolo, M., Cholongitas, E., Davies, N., Tibballs, J., Meyer, T., Patch, D. W., & Burroughs, A. K. (2007) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-006-0062-3 · Cited by 791
Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
Villanueva, A., Chiang, D. Y., Newell, P., Peix, J., Thung, S., Alsinet, C., Tovar, V., Roayaie, S., Minguez, B., Sole, M., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.08.008 · Cited by 733
Simplified Staging for Hepatocellular Carcinoma
Vauthey, J. N., Lauwers, G. Y., Esnaola, N. F., Do, K.-A., Belghiti, J., Mirza, N., Curley, S. A., Ellis, L. M., Regimbeau, J.-M., Rashid, A., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1527 · Cited by 700
Self-citationMarrero, J. A., Fontana, R. J., Su, G. L., Conjeevaram, H. S., Emick, D. M., & Lok, A. S. (2002) · Hepatology · doi:10.1002/hep.1840360609 · Cited by 660
Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study
Chang, M.-H., You, S.-L., Chen, C.-J., Liu, C.-J., Lee, C.-M., Lin, S.-M., Chu, H.-C., Wu, T.-C., Yang, S.-S., Kuo, H.-S., et al. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp288 · Cited by 635
Lin, S.-M., Lin, C.-J., Lin, C.-C., Hsu, C.-W., & Chen, Y.-C. (2005) · Gut · doi:10.1136/gut.2004.045203 · Cited by 592 · cited 1×
“3% after RFA compared with 0% after surgery.(87) However,”
Leung, T. W. T., Tang, A. M. Y., Zee, B., Lau, W. Y., Lai, P. B. S., Leung, K. L., Lau, J. T. F., Yu, S. C. H., & Johnson, P. J. (2002) · Cancer · doi:10.1002/cncr.10384 · Cited by 583
Chemoembolization for hepatocellular carcinoma
Bruix, J., Sala, M., & Llovet, J. M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.032 · Cited by 569
Ringe, B., Pichlmayr, R., Wittekind, C., & Tusch, G. (1991) · World Journal of Surgery · doi:10.1007/bf01659064 · Cited by 565
(2000) · Hepatology · doi:10.1053/he.2000.5628 · Cited by 521
Siegel, A. B., Cohen, E. I., Ocean, A., Lehrer, D., Goldenberg, A., Knox, J. J., Chen, H., Clark-Garvey, S., Weinberg, A., Mandeli, J., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.9947 · Cited by 506
Zhu, A. X., Sahani, D. V., Duda, D. G., di Tomaso, E., Ancukiewicz, M., Catalano, O. A., Sindhwani, V., Blaszkowsky, L. S., Yoon, S. S., Lahdenranta, J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.9908 · Cited by 477
Phase II Study of Erlotinib (OSI-774) in Patients With Advanced Hepatocellular Cancer
Philip, P. A., Mahoney, M. R., Allmer, C., Thomas, J., Pitot, H. C., Kim, G., Donehower, R. C., Fitch, T., Picus, J., & Erlichman, C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.14.696 · Cited by 462
Hepatocellular Carcinoma – Epidemiological Trends and Risk Factors
Schütte, K., Bornschein, J., & Malfertheiner, P. (2009) · Digestive Diseases · doi:10.1159/000218339 · Cited by 441
Koffler, M. (1965) · The Lancet · doi:10.1016/s0140-6736(65)92594-8 · Cited by 431
RECIST revisited: A review of validation studies on tumour assessment
Therasse, P., Eisenhauer, E. A., & Verweij, J. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.026 · Cited by 422
Pelletier, G., Roche, A., Ink, O., Anciaux, M. L., Derhy, S., Rougier, P., Lenoir, C., Attali, P., & Etienne, J.-P. (1990) · Journal of Hepatology · doi:10.1016/0168-8278(90)90110-d · Cited by 417
Yao, F. Y., Ferrell, L., Bass, N. M., Bacchetti, P., Ascher, N. L., & Roberts, J. P. (2002) · Liver Transplantation · doi:10.1053/jlts.2002.34892 · Cited by 408
Self-citationMetabolic syndrome and hepatocellular carcinoma: Two growing epidemics with a potential link
Siegel, A. B., & Zhu, A. X. (2009) · Cancer · doi:10.1002/cncr.24687 · Cited by 399
Lucey, M. R., Brown, K. A., Everson, G. T., Fung, J. J., Gish, R., Keeffe, E. B., Kneteman, N. M., Lake, J. R., Martin, P., McDiarmid, S. V., et al. (1997) · Liver Transplantation and Surgery · doi:10.1002/lt.500030613 · Cited by 391
Yao, F. Y., Bass, N. M., Nikolai, B., Davern, T. J., Kerlan, R., Wu, V., Ascher, N. L., & Roberts, J. P. (2002) · Liver Transplantation · doi:10.1053/jlts.2002.34923 · Cited by 389
Self-citationTreatment of hepatocellular carcinoma: A systematic review of randomized controlled trials
Simonetti, R. G., Liberati, A., Angiolini, C., & Pagliaro, L. (1997) · Annals of Oncology · doi:10.1023/a:1008285123736 · Cited by 380
Liver cancer: Descriptive epidemiology and risk factors other than HBV and HCV infection
Chuang, S.-C., Vecchia, C. L., & Boffetta, P. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.10.040 · Cited by 365
Diagnosis of hepatocellular carcinoma
Bialecki, E. S., & Di Bisceglie, A. M. (2005) · HPB · doi:10.1080/13651820410024049 · Cited by 334
Ito, Y., Sasaki, Y., Horimoto, M., Wada, S., Tanaka, Y., Kasahara, A., Ueki, T., Hirano, T., Yamamoto, H., Fujimoto, J., et al. (1998) · Hepatology · doi:10.1002/hep.510270409 · Cited by 334
Thomas, M. B., Morris, J. S., Chadha, R., Iwasaki, M., Kaur, H., Lin, E., Kaseb, A., Glover, K., Davila, M., & Abbruzzese, J. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.3301 · Cited by 334
Self-citationAzad, N. S., Posadas, E. M., Kwitkowski, V. E., Steinberg, S. M., Jain, L., Annunziata, C. M., Minasian, L., Sarosy, G., Kotz, H. L., Premkumar, A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.8332 · Cited by 332
Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma
Thomas, M. B., Chadha, R., Glover, K., Wang, X., Morris, J., Brown, T., Rashid, A., Dancey, J., & Abbruzzese, J. L. (2007) · Cancer · doi:10.1002/cncr.22886 · Cited by 306
Self-citationFactors affecting long-term outcome after hepatic resection for hepatocellular carcinoma
Vauthey, J.-N., Klimstra, D., Franceschi, D., Tao, Y., Fortner, J., Blumgart, L., & Brennan, M. (1995) · The American Journal of Surgery · doi:10.1016/s0002-9610(99)80106-8 · Cited by 303
Realdi, G., The Investigators of the European Concerted Action on Viral Hepatitis (EUROHEP), Fattovich, G., Hadziyannis, S., Schalm, S. W., Almasio, P., Sanchez-Tapias, J., Christensen, E., Giustina, G., & Noventa, F. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(94)80115-0 · Cited by 301
伊藤, 善. (1998) · doi:10.11501/3155565 · Cited by 300
Cucchetti, A., Ercolani, G., Vivarelli, M., Cescon, M., Ravaioli, M., La Barba, G., Zanello, M., Grazi, G. L., & Pinna, A. D. (2006) · Liver Transplantation · doi:10.1002/lt.20761 · Cited by 296
Faivre, S., Raymond, E., Boucher, E., Douillard, J., Lim, H. Y., Kim, J. S., Zappa, M., Lanzalone, S., Lin, X., DePrimo, S., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70171-8 · Cited by 290
Predictors and patterns of recurrence after resection of hepatocellular carcinoma
Cha, C., Fong, Y., Jarnagin, W. R., Blumgart, L. H., & DeMatteo, R. P. (2003) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2003.07.003 · Cited by 281
Self-citationZimmerman, M. A. (2008) · Archives of Surgery · doi:10.1001/archsurg.2007.39 · Cited by 278
Teh, S. H., Christein, J., Donohue, J., Que, F., Kendrick, M., Farnell, M., Cha, S., Kamath, P., Kim, R., & Nagorney, D. M. (2005) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2005.09.008 · Cited by 255
Gunderson, L. L., Jessup, J. M., Sargent, D. J., Greene, F. L., & Stewart, A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.9194 · Cited by 244
Shim, J. H., Park, J., Kim, J. H., An, M., Kong, S., Nam, B., Choi, J., Kim, H. B., Lee, W. J., & Kim, C. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00909.x · Cited by 239
Hong, S. N., Lee, S.-Y., Choi, M. S., Lee, J. H., Koh, K. C., Paik, S. W., Yoo, B. C., Rhee, J. C., Choi, D., Lim, H. K., et al. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000152746.72149.31 · Cited by 222
Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma
Kane, R. C., Farrell, A. T., Madabushi, R., Booth, B., Chattopadhyay, S., Sridhara, R., Justice, R., & Pazdur, R. (2009) · The Oncologist · doi:10.1634/theoncologist.2008-0185 · Cited by 221
Dual-Tracer PET/CT Imaging in Evaluation of Metastatic Hepatocellular Carcinoma
Ho, C.-L., Chen, S., Yeung, D. W. C., & Cheng, T. K. C. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.036673 · Cited by 210
Schoenleber, S. J., Kurtz, D. M., Talwalkar, J. A., Roberts, L. R., & Gores, G. J. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605017 · Cited by 207
Self-citationEpidemiology of hepatitis B in the United States #
Kim, R. W. (2009) · Hepatology · doi:10.1002/hep.22975 · Cited by 207
Dempsey, D. T. (2006) · Yearbook of Gastroenterology · doi:10.1016/s0739-5930(08)70399-4 · Cited by 201
Nannini, M., Pantaleo, M. A., Maleddu, A., Astolfi, A., Formica, S., & Biasco, G. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.10.006 · Cited by 170
FDA Approves Sorafenib for Patients With Inoperable Liver Cancer
Lang, L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.12.037 · Cited by 159
Functional Genomics of Hepatocellular Carcinoma
Thorgeirsson, S. S., Lee, J., & Grisham, J. W. (2006) · Hepatology · doi:10.1002/hep.21063 · Cited by 137
Bridging Locoregional Therapy for Hepatocellular Carcinoma Prior to Liver Transplantation
Heckman, J. T., DeVera, M., Marsh, J. W., Fontes, P., Amesur, N. B., Holloway, S. E., Nalesnik, M. A., Geller, D. A., Steel, J. L., & Gamblin, T. C. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0071-3 · Cited by 136
Page, J. M., & Harrison, S. A. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.07.007 · Cited by 136
Cho, C. S., Gönen, M., Shia, J., Kattan, M. W., Klimstra, D. S., Jarnagin, W. R., D'Angelica, M. I., Blumgart, L. H., & DeMatteo, R. P. (2007) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2007.07.031 · Cited by 133
Development of sorafenib and other molecularly targeted agents in hepatocellular carcinoma
Zhu, A. X. (2007) · Cancer · doi:10.1002/cncr.23175 · Cited by 128
Expanded Criteria for Liver Transplantation in Patients with Cirrhosis and Hepatocellular Carcinoma
Silva, M., Moya, A., Berenguer, M., Sanjuán, F., López‐Andújar, R., Pareja, E., Torres-Quevedo, R., Aguilera, V., Montalvá, E. M., de Juan, M., et al. (2008) · Liver Transplantation · doi:10.1002/lt.21576 · Cited by 122
Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab
Finn, R. S., & Zhu, A. X. (2009) · Expert Review of Anticancer Therapy · doi:10.1586/era.09.6 · Cited by 122
Taura, K., Ikai, I., Hatano, E., Yasuchika, K., Nakajima, A., Tada, M., Seo, S., Machimoto, T., & Üemoto, S. (2007) · Surgery · doi:10.1016/j.surg.2007.05.009 · Cited by 113
Huynh, H. T., Ngo, V. C., Koong, H. N., Poon, D. Y. H., Choo, S. P., Toh, H. C., Thng, C. H., Chow, P. K. H., Ong, H. S., Chung, A. Y. F., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.10.008 · Cited by 110
Palavecino, M. E., Chun, Y. S., Madoff, D. C., et al. (2009) · Surgery · doi:10.1016/j.surg.2008.10.009 · Cited by 110
Growth factors in liver development, regeneration and carcinogenesis
Fausto, N. (1991) · Progress in Growth Factor Research · doi:10.1016/0955-2235(91)90008-r · Cited by 109
Shirakami, Y., Shimizu, M., Adachi, S., Sakai, H., Nakagawa, T., Yasuda, Y., Tsurumi, H., Hara, Y., & Moriwaki, H. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01241.x · Cited by 106
Höpfner, M., Schuppan, D., & Scherübl, H. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.1 · Cited by 106
Hepatogenous diabetes. Current views of an ancient problem
García‐Compeán, D., Jáquez-Quintana, J. O., & Maldonado-Garza, H. J. (2009) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31805-8 · Cited by 105
Shah, S. A., Cleary, S. P., Tan, J. C. C., Wei, A. C.-C., Gallinger, S., Grant, D. R., & Greig, P. D. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9443-3 · Cited by 104
Hepatitis C Virus and Hepatocellular Carcinoma
Colombo, M. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007116 · Cited by 102
TACE versus TAE as therapy for hepatocellular carcinoma
Pleguezuelo, M., Marelli, L., Misseri, M., Germani, G., Calvaruso, V., Xirouchakis, E., Manousou, P., & Burroughs, A. K. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.10.1623 · Cited by 91
Ikai, I., Takayasu, K., Omata, M., Okita, K., Nakanuma, Y., Matsuyama, Y., Makuuchi, M., Kojiro, M., Ichida, T., Arii, S., et al. (2006) · Journal of Gastroenterology · doi:10.1007/s00535-006-1878-y · Cited by 90
Collette, S., Bonnetain, F., Paolettí, X., Doffoël, M., Bouché, O., Raoul, J., Rougier, P. R., Masskouri, F., Bedenne, L., & Barbare, J. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn030 · Cited by 89
McKillop, I. H., Schmidt, C. M., Cahill, P. A., & Sitzmann, J. V. (1997) · Hepatology · doi:10.1002/hep.510260615 · Cited by 81
Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma
Huynh, H. T., Chow, P. K. H., Palanisamy, N., Salto‐Tellez, M., Goh, B. C., Lee, C. K., Anaji, S., Lee, H. S., Kalpana, R., Yu, K., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.02.022 · Cited by 79
mTOR inhibitors for hepatocellular cancer: a forward-moving target
Treiber, G. (2009) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.9.2.247 · Cited by 78
Şahin, M., Allard, B. L., Yates, M., Powell, J. G., Wang, X.-L., HAY, I. D., Zhao, Y., Goellner, J. R., Sebo, T. J., Grebe, S. K. G., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1203 · Cited by 77
Georgiades, C. S., Liapi, E. A., Frangakis, C., Park, J.-U., Kim, H. W., Hong, K. K., & Geschwind, J.-F. H. (2006) · Journal of Vascular and Interventional Radiology · doi:10.1097/01.rvi.0000236608.91960.34 · Cited by 70
IHPBA concordant classification of primary liver cancer: working group report
Makuuchi, M., Belghiti, J., Belli, G., Fan, S.-T., Lau, J. W. Y., Ringe, B., Strasberg, S. M., Vauthey, J., Yamaoka, Y., & Yamasaki, S. (2003) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s10534-002-0808-6 · Cited by 69
Self-citationKanda, M., Nomoto, S., Nishikawa, Y., Sugimoto, H., Kanazumi, N., Takeda, S., & Nakao, A. (2008) · Journal of Surgical Oncology · doi:10.1002/jso.21095 · Cited by 69
Management of advanced hepatocellular carcinoma in the era of targeted therapy
Yau, T. C. C., Chan, P., Epstein, R. J., & Poon, R. T. P. (2008) · Liver International · doi:10.1111/j.1478-3231.2008.01916.x · Cited by 69
Self-citationLu, W., Dong, J., Huang, Z., Guo, D., Liu, Y., & Shi, S. J. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05527.x · Cited by 69
Chaparro, M., MORENO, L. G., Trapero-Marugán, M., MEDINA, J., & Moreno‐Otero, R. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03857.x · Cited by 67
Expression of p27, cyclin E and cyclin A in hepatocellular carcinoma and its clinical significance
Zhou, Q., He, Q., & Liang, L. (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i11.2450 · Cited by 55
Ren, N. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i24.3911 · Cited by 53
Management of Early Hepatocellular Carcinoma in Patients with Well-Compensated Cirrhosis
Cunningham, S. C., Tsai, S., Marques, H. P., Mira, P., Cameron, A. M., Barroso, E., Philosophe, B., & Pawlik, T. M. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0364-1 · Cited by 47
Transcriptomic profiling identifies a PU.1 regulatory network in macrophages
Weigelt, K., Lichtinger, M., Rehli, M., & Langmann, T. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.01.067 · Cited by 33
Early development of sunitinib in hepatocellular carcinoma
Zhu, A. X., & Raymond, É. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.9.1.143 · Cited by 29
Nuzzo, G., Giuliante, F., Gauzolino, R., et al. (2007) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2006.11.029 · Cited by 22
Role of nonalcoholic fatty liver disease in hepatocellular carcinoma
Chávez-Tapia, N. C., Méndez‐Sánchez, N., & Uribe, M. (2009) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31824-1 · Cited by 22
Prevention and treatment of hepatocellular carcinoma
Omata, M., & Yoshida, H. (2004) · Liver Transplantation · doi:10.1002/lt.20046 · Cited by 20
Exploiting novel molecular targets in gastrointestinal cancers
Wang, W., & Hidalgo, M. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i44.5845 · Cited by 18
Can Therapy of Hepatitis C Affect the Development of Hepatocellular Carcinoma?
Kulik, L. (2006) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2006.0065 · Cited by 9
Cited by
Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
Jacobson, I. M., McHutchison, J. G., Dusheiko, G., Di Bisceglie, A. M., Reddy, K. R., Bzowej, N. H., Marcellin, P., Muir, A. J., Ferenci, P., Flisiak, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1012912 · Cited by 2,398
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
Park, J., Chen, M., Colombo, M., Roberts, L. R., Schwartz, M., Chen, P., Kudo, M., Johnson, P., Wagner, S., Orsini, L. S., et al. (2015) · Liver International · doi:10.1111/liv.12818 · Cited by 1,245
Lencioni, R., de Baere, T., Soulen, M. C., Rilling, W. S., & Geschwind, J. H. (2016) · Hepatology · doi:10.1002/hep.28453 · Cited by 732
Salem, R., Lewandowski, R. J., Kulik, L., Wang, E., Riaz, A., Ryu, R. K., Sato, K. T., Gupta, R., Nikolaidis, P., Miller, F. H., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.10.049 · Cited by 650
Zhu, A. X., Rosmorduc, O., Evans, T. R. J., Ross, P. J., Santoro, A., Carrilho, F. J., Bruix, J., Qin, S., Thuluvath, P. J., Llovet, J. M., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.7746 · Cited by 576
Metadata
- Authors
- Thomas, M. B., Jaffe, D., Choti, M. M., Belghiti, J., Curley, S., Fong, Y., Gores, G., Kerlan, R., Merle, P., O'Neil, B., Poon, R., Schwartz, L., Tepper, J., Yao, F., Haller, D., Mooney, M., & Venook, A.
- Venue
- Journal of Clinical Oncology
- Published
- 2010-09-01
- Volume
- 28
- Issue
- 25
- Pages
- 3994-4005
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2103362199
- Cited by
- 394
- References
- 108
- FWCI
- 18.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.